Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Pauliina Lehtolainen‐Dalkilic
Observed name:
Pauliina Lehtolainen-Dalkilic
Institution:
Finnish Medicines Agency Fimea
Observed institution:
Finnish Medicines Agency Fimea
OpenAlex ID:
A5033739964
Avidin Fusion Protein-Expressing Lentiviral Vector for Targeted Drug Delivery
2009
·
Hanna P. Lesch
, Jere T. Pikkarainen
, et al.
·
Human Gene Therapy
·
22
Targeted delivery via avidin fusion protein: Intracellular fate of biotinylated doxorubicin derivative and cellular uptake kinetics and biodistribution of biotinylated liposomes
2012
·
Suvi K. Soininen
, Pauliina Lehtolainen-Dalkilic
, et al.
·
European Journal of Pharmaceutical Sciences
·
20
Efficient gene therapy based targeting system for the treatment of inoperable tumors
2012
·
Thomas Wirth
, Jere Tuomas Pikkarainen
, et al.
·
The Journal of Gene Medicine
·
6
A novel strategy for the synthesis of enzymatically stable biotin–DOTA conjugates for in vivo use
2011
·
Petri A. Turhanen
, Janne Weisell
, et al.
·
MedChemComm
·
4
Translating non-clinical proof-of-concept data into paediatric development decisions: the case of HER2-targeting antibody-drug conjugates
2026
·
Pauliina Lehtolainen-Dalkilic
, Caoimhin G. Concannon
, et al.
·
EJC Paediatric Oncology
PDF
Integrating non-clinical and clinical evidence for prioritisation in paediatric oncology drug development: Regulatory experience with three PARP inhibitors
2026
·
Karen Van Malderen
, Sofie Peirs
, et al.
·
EJC Paediatric Oncology
PDF
Show more works
View as search
Works count:
6
Citation count:
52
H-index:
4
I10-index:
2
Year
Topic
Type